The U.S. Agency for International Development (USAID) has committed $2.3 million to malaria prevention and cure with its recent partnership with Swiss Pharma (Swipha) seen at expanding access to essential medicines in Nigeria and West Africa.
Under the partnership, the USAID is expected to procur
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
Seyi John Salau
Seyi John Salau is a BusinessDay Correspondent with interest in development journalism, which tells stories that connect the people, brands, and the government. SeyiJohn is also a media professional with BSc, Mass Communition (ACU); Masters of School Media (MSM, Ibadan) & MSc, Mass Communication (Caleb).
